The research of the clinical effect and mechanism of Zhishen Tiaoxing Tuina therapy on Chronic Fatigue Immune Dysfunction Syndrome

Early Phase 1

• Conditions: Chronic Fatigue Syndrome; 8E49 (ICD-11)

• Registration Number: ITMCTR2024000081
• Lead Sponsor: Affiliated Hospital of Changchun University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Meet the diagnostic criteria of disease; 2) Age between 18 and 60 years old, male and female; 3) The patient was in normal mind and could express his feelings to the doctor with fluent speech; 4) Patients have good compliance, can abide by the trial protocol and cooperate to complete the treatment project; 5)Patients agreed to receive the study regimen and signed the informed consent form.

Exclusion Criteria

1) Those who did not meet the study inclusion criteria; 2) any active disease that could explain chronic fatigue syndrome (definite diagnosis of gastrointestinal organic disease, hepatic and renal insufficiency, tumor or serious cardiovascular and cerebrovascular disease, endocrine system disease, motor system disease, autoimmune disease, infectious disease, diabetes mellitus, drug side effects or other mental disease); 3) pregnant or lactating women; 4) suffering from infectious diseases or skin infection damage, not suitable for Tuina treatment; 5) those who had significant changes in diet before the study; 6) patients who have received relevant treatment within 30 days or are participating in other clinical trials that may affect the evaluation of the results of this study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified